du Bois A - Search Results

1

Bevacizumab in the treatment of ovarian cancer.

Heitz F, Harter P, Barinoff J, Beutel B, Kannisto P, Grabowski JP, Heitz J, Kurzeder C, du Bois A. Heitz F, et al. Among authors: du bois a. Adv Ther. 2012 Sep;29(9):723-35. doi: 10.1007/s12325-012-0041-9. Epub 2012 Aug 21. Adv Ther. 2012. PMID: 22941523 Review.

2

The integration of anthracyclines in the treatment of advanced ovarian cancer.

Lück HJ, Du Bois A, Weber B, Pfisterer J, Goupil A, Kuhn W, Barats JC, Blohmer J, Mousseau M, Schröder W, Meier W, Möbus V, Richter B; AGO-GINECO Intergroup. Lück HJ, et al. Among authors: du bois a. Int J Gynecol Cancer. 2001;11 Suppl 1:34-8. Int J Gynecol Cancer. 2001. PMID: 11489001

3

Improving first-line therapy of advanced ovarian cancer - the AGO Ovarian Cancer Study Group perspective.

du Bois A, Pfisterer J, Meier W, Wagner U. du Bois A, et al. Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:169-71. doi: 10.1111/j.1525-1438.2003.t01-2-13352.x. Int J Gynecol Cancer. 2003. PMID: 14656275

4

Future options for first-line therapy of advanced ovarian cancer.

Du Bois A, Pfisterer J. Du Bois A, et al. Int J Gynecol Cancer. 2005 May-Jun;15 Suppl 1:42-50. doi: 10.1111/j.1525-1438.2005.15356.x. Int J Gynecol Cancer. 2005. PMID: 15839958 Free article. Review.

5

Non-enrolment of ovarian cancer patients in clinical trials: reasons and background.

Harter P, du Bois A, Schade-Brittinger C, Burges A, Wollschlaeger K, Gropp M, Schmalfeldt B, Huober J, Staehle A, Pfisterer J. Harter P, et al. Among authors: du bois a. Ann Oncol. 2005 Nov;16(11):1801-5. doi: 10.1093/annonc/mdi367. Epub 2005 Aug 9. Ann Oncol. 2005. PMID: 16091427 Free article.

6

The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence.

Harter P, du Bois A. Harter P, et al. Among authors: du bois a. Curr Opin Oncol. 2005 Sep;17(5):505-14. doi: 10.1097/01.cco.0000174166.06734.c7. Curr Opin Oncol. 2005. PMID: 16093804 Review.

7

Cisplatinum rechallenge in relapsed ovarian cancer patients with platinum reinduction therapy and carboplatin hypersensitivity.

Kandel MJ, Loehr A, Harter P, Traut A, Gnauert K, du Bois A. Kandel MJ, et al. Among authors: du bois a. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):780-4. doi: 10.1111/j.1525-1438.2005.00136.x. Int J Gynecol Cancer. 2005. PMID: 16174224 Free article.

8

Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.

Harter P, du Bois A, Hahmann M, Hasenburg A, Burges A, Loibl S, Gropp M, Huober J, Fink D, Schröder W, Muenstedt K, Schmalfeldt B, Emons G, Pfisterer J, Wollschlaeger K, Meerpohl HG, Breitbach GP, Tanner B, Sehouli J; Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Committee; AGO Ovarian Cancer Study Group. Harter P, et al. Among authors: du bois a. Ann Surg Oncol. 2006 Dec;13(12):1702-10. doi: 10.1245/s10434-006-9058-0. Ann Surg Oncol. 2006. PMID: 17009163 Clinical Trial.

9

The role of surgery in advanced and recurrent ovarian cancer.

du Bois A, Harter P. du Bois A, et al. Ann Oncol. 2006 Sep;17 Suppl 10:x235-40. doi: 10.1093/annonc/mdl266. Ann Oncol. 2006. PMID: 17018731 Review. No abstract available.

10

Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer.

Harter P, Gnauert K, Hils R, Lehmann TG, Fisseler-Eckhoff A, Traut A, du Bois A. Harter P, et al. Among authors: du bois a. Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1238-44. doi: 10.1111/j.1525-1438.2007.00931.x. Epub 2007 Apr 12. Int J Gynecol Cancer. 2007. PMID: 17433064

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters